The population of people with immunodeficiency is increasing due to the accelerating pace of life, increase in work pressure, and lack of exercise, irregularity of diet and rest, and problems of environmental pollution. Chinese herbal medicines have been shown to improve immunity, with little to no side effects. In recent years, studies have shown that Shcisandrol A (Sch A) regulates immune functioning and inhibits inflammation of the nervous system. The current study used gene expression profiling of spleen tissue to screen differentially expressed genes related to Sch A treatment on cyclophosphamide (Cy)-induced immunosuppressed mice. The differentially expressed gene-related pathways were analyzed by gene ontology function cluster analysis and qPCR. Five genes related to immune functioning were found to be regulated by Sch A treatment: Mapk3, Pik3r1, Pik3r5, Ikbkg, and Cd247. qPCR analysis showed that all five genes were significantly down-regulated in mice treated with Sch A compared to untreated immunosuppressed mice. These results suggest potential mechanisms through which Sch A regulates immune functioning.
MunnLL. (2016) Cancer and inflammation. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 2, e1370.
2.
MajdanA, Ziober-MalinowskaP. (2016) Immunity and cancer associated thrombosis. Wiadomosci Lekarskie, 4, 686–692.
3.
FujiokaY, NishikawaH. (2016) Basics of cancer immunotherapy. Rinsho Ketsueki, 11, 2346–2354.
4.
LevyG, BonnevalleM, RocourtN, SudourH, DefachellesAS. (2015) Necrotizing enterocolitis as an adverse effect of recombinant interleukin-2 and Ch14.18 in maintenance therapy for high-risk neuroblastoma. Journal of Pediatric Hematology Oncology, 4, e250-252.
5.
VermaP, DayalS, JainVK, AmraniA. (2016) Alopecia universalis as a side effect of pegylated interferon alpha-ribavirin combination therapy for hepatitis C: a rare case report. Journal of Chemotherapy, 1–3.
6.
HeFY, DengKW, ZengJL, DaiRW, XiaZS, LiuWL, ShiJL. (2013) Current development of rapid high-throughout determination technology for total components of traditional Chinese medicines and formula and synthetic immunity chip method. Zhongguo Zhong Yao Za Zhi, 20, 3164–3168.
7.
MaHD, DengYR, TianZ, LianZX. (2012) Traditional Chinese medicine and immune regulation. Clinical Reviews in Allergy & Immunology, 3, 229–241.
8.
ChiuPY, MakDH, PoonMK, KoKM. (2002) In vivo antioxidant action of a lignan-enriched extract of Schisandra fruit and an anthraquinone-containing extract of Polygonum root in comparison with schisandrin B and emodin. Planta Medica, 11, 951–956.
9.
LinRD, MaoYW, LeuSJ, HuangCY, LeeMH. (2011) The immuno-regulatory effects of Schisandra chinensis and its constituents on human monocytic leukemia cells. Molecules, 6, 4836–4849.
10.
MoonPD, JeongHJ, KimHM. (2012) Effects of schizandrin on the expression of thymic stromal lymphopoietin in human mast cell line HMC-1. Life Sciences, 11-12, 384–388.
11.
ParkSY, ParkDJ, KimYH, KimY, KimSG, ShonKJ, ChoiYW, LeeSJ. (2011) Upregulation of heme oxygenase-1 via PI3K/Akt and Nrf-2 signaling pathways mediates the anti-inflammatory activity of Schisandrin in Porphyromonas gingivalis LPS-stimulated macrophages. Immunology Letters, 1-2, 93–101.
12.
MotoyoshiY, KaminodaK, SaitohO, HamasakiK, NakaoK, IshiiN, NagayamaY, EguchiK. (2006) Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide. Oncology Reports, 1, 141–146.
13.
SharonN. (1983) Lectin receptors as lymphocyte surface markers. Advances in Immunology, 34, 213–298.
14.
Fuentes-ArderiuX, MestreM. (2009) Description of flow cytometry examinations related to human cell differentiation molecules in clinical immunology. Cytometry Part B-Clinical Cytometry, 4, 291–293.
15.
HuangR, ZhaoM, YangX, HuangJ, YangY, ChenB, TanJ, LiZ, LvY, JiG. (2013) Effects of Prunella vulgaris on the mice immune function. PLOS ONE, 10, e77355.
16.
YuanH, PerryCN, HuangC, Iwai-KanaiE, CarreiraRS, GlembotskiCC, GottliebRA. (2009) LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. American Journal of Physiology-heart and Circulatory Physiology, 2, H470-479.
17.
CantleyLC. (2002) The phosphoinositide 3-kinase pathway. Science, 5573, 1655–1657.
18.
NicholsonKM, AndersonNG. (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cellular Signalling, 5, 381–395.
19.
Thauvin-RobinetC, AuclairM, DuplombL, Caron-DebarleM, AvilaM, St-OngeJ, Le MerrerM, Le LuyerB, HeronD, Mathieu-DramardM, BitounP, PetitJM, OdentS, AmielJ, PicotD, CarmignacV, ThevenonJ, CallierP, LavilleM, ReznikY, FagourC, NunesML, CapeauJ, LascolsO, HuetF, FaivreL, VigourouxC, RivièreJB. (2013) PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. American Journal of Human Genetics, 1, 141–149.
20.
VanhaesebroeckB, StephensL, HawkinsP. (2012) PI3K signalling: the path to discovery and understanding. Nature Reviews Molecular Cell Biology, 3, 195–203.
21.
KandouzM, HaidaraK, ZhaoJ, BrissonML, BatistG. (2010) The EphB2 tumor suppressor induces autophagic cell death via concomitant activation of the ERK1/2 and PI3K pathways. Cell Cycle, 2, 398–407.
22.
BlagosklonnyMV. (2010) Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program. Cell Cycle, 16, 3151–3156.
23.
YokoiK, FidlerIJ. (2004) Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine. Clinical Cancer Research, 7, 2299–2306.
SestakAL, ShaverTS, MoserKL, NeasBR, HarleyJB. (1999) Familial aggregation of lupus and autoimmunity in an unusual multiplex pedigree. Journal of Rheumatology, 7, 1495–1499.
26.
ZhaoL, MaH, JiangZ, JiangY, MaN. (2014) Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients. Clinical and Experimental Immunology, 1, 212–218.
27.
HomG, GrahamRR, ModrekB, TaylorKE, OrtmannW, GarnierS, LeeAT, ChungSA, FerreiraRC, PantPV, BallingerDG, KosoyR, DemirciFY, KambohMI, KaoAH, TianC, GunnarssonI, BengtssonAA, Rantapää-DahlqvistS, PetriM, ManziS, SeldinMF, RönnblomL, SyvänenAC, CriswellLA, GregersenPK, BehrensTW. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. New England Journal of Medicine, 9, 900–909.
28.
LauCS, YinG, MokMY. (2006) Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus, 11, 715–719.
29.
ArdoinSP, PisetskyDS. (2008) Developments in the scientific understanding of lupus. Arthritis Research & Therapy, 5, 218.
30.
Lee-KirschMA, GongM, SchulzH, RuschendorfF, SteinA, PfeifferC, BallariniA, GahrM, HubnerN, LinneM. (2006) Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. American Journal of Human Genetics, 4, 731–737.
31.
JorgensenSE, BottgerP, Kofod-OlsenE, HolmM, MorkN, OrntoftTF, SorensenUB, Bernth-JensenJM, HerlinT, VeirumJ, LarsenCS, Østergaard L, HartmannR, ChristiansenM, MogensenTH. (2016) Ectodermal dysplasia with immunodeficiency caused by a branch-point mutation in IKBKG/NEMO. Journal of Allergy and Clinical Immunology, 6, 1706-1709 e1704.
32.
KaracaNE, AksuG, UlusoyE, CavusogluC, Oleaga-QuintasC, Nieto-PatlanA, RichardME, DeswarteC, CasanovaJL, BustamanteJ, (2016) Disseminated BCG infectious disease and hyperferritinemia in a patient with a novel NEMO mutation. Journal of Investigational Allergology and Clinical Immunology, 4, 268–271.
33.
YeJ, FangL, ZhengH, ZhangY, ChenJ, ZhangZ, WangJ, LiS, LiR, BolundL. (2006) WEGO: a web tool for plotting GO annotations. Nucleic Acids Research, 34 (Web Server issue), W293-297.
34.
Rodriguez-TomeP, StoehrPJ, CameronGN, FloresTP. (1996) The European Bioinformatics Institute (EBI) databases. Nucleic Acids Research, 24, 6–12.
35.
HuangDW, ShermanBT, TanQ, CollinsJR, AlvordWG, RoayaeiJ, StephensR, BaselerMW, LaneHC, LempickiRA. (2007) The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biology, 9, R183.
36.
de AlmeidaME, KoruO, SteurerF, HerwaldtBL, da SilvaAJ. (2017) Detection and Differentiation of Leishmania spp. in Clinical Specimens by Use of a SYBR Green-Based Real-Time PCR Assay. Journal of Clinical Microbiology, 55, 281-290.
37.
ShiQ, ZhouW, ChenC, ZhangBY, XiaoK, ZhangXC, ShenXJ, LiQ, DengLQ, DongJH, LinWQ, HuangP, JiangWJ, LvJ, HanJ, DongXP. (2015) The features of genetic prion diseases based on Chinese surveillance program. PlOS ONE, 10, e0139552.
